These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 1165472)

  • 1. Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.
    Sassa S; Solish G; Levere RD; Kappas A
    J Exp Med; 1975 Sep; 142(3):722-31. PubMed ID: 1165472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.
    Sassa S; Zalar GL; Kappas A
    J Clin Invest; 1978 Feb; 61(2):499-508. PubMed ID: 621286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase.
    Lamon JM; Frykholm BC; Tschudy DP
    J Med Genet; 1979 Apr; 16(2):134-9. PubMed ID: 458830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis of acute intermittent porphyria. Usefulness and limitations of the erythrocyte uroporphyrinogen I synthase assay.
    Bottomley SS; Bonkowsky HL; Kreimer-Birnbaum M
    Am J Clin Pathol; 1981 Aug; 76(2):133-9. PubMed ID: 7270494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria.
    Anderson KE; Alvares AP; Sassa S; Kappas A
    Clin Pharmacol Ther; 1976 Jan; 19(1):47-54. PubMed ID: 1245093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria].
    Iwanov ED; Adjarov D; Tsanev R
    Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte uroporphyrinogen I synthase activity as an indicator of acute porphyria.
    Forman DT
    Ann Clin Lab Sci; 1989; 19(2):128-32. PubMed ID: 2751241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal erythrocyte uroporphyrinogen I synthase in a kindred with acute intermittent porphyria.
    Mustajoki P
    Ann Intern Med; 1981 Aug; 95(2):162-6. PubMed ID: 7258864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities.
    McColl KE; Moore MR; Thompson GG; Goldberg A
    J Med Genet; 1982 Aug; 19(4):271-6. PubMed ID: 7120315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red cell uroporphyrinogen I synthetase in acute intermittent porphyria.
    Mustajoki P
    Ann Clin Res; 1976; 8 Suppl 17():133-8. PubMed ID: 1008483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the porphobilinogen deaminase deficiency in acute intermittent porphyria. Immunologic evidence for heterogeneity of the genetic defect.
    Anderson PM; Reddy RM; Anderson KE; Desnick RJ
    J Clin Invest; 1981 Jul; 68(1):1-12. PubMed ID: 7251856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A
    Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Glucose effect" and rate limiting function of uroporphyrinogen synthase on porphyrin metabolism in hepatocyte culture: relationship with human acute hepatic porphyrias.
    Doss M; Sixel-Dietrich F; Verspohl F
    J Clin Chem Clin Biochem; 1985 Sep; 23(9):505-13. PubMed ID: 4067519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute intermittent porphyria. Detection of asymptomatic carriers of the genetic defect].
    Grandchamp B; Grelier M; Nordmann Y
    Nouv Presse Med; 1975 Jun; 4(24):1801-2. PubMed ID: 1161481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with the red cell uroporphyrinogen synthase (URO-S) assay in kindreds with acute intermittent porphyria (AIP).
    Kreimer-Birnbaum M; Bonkowsky HL; Bottomley SS
    Int J Biochem; 1980; 12(5-6):807-10. PubMed ID: 7450137
    [No Abstract]   [Full Text] [Related]  

  • 16. Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria.
    Unzu C; Sampedro A; Mauleón I; Vanrell L; Dubrot J; de Salamanca RE; González-Aseguinolaza G; Melero I; Prieto J; Fontanellas A
    J Hepatol; 2010 Mar; 52(3):417-24. PubMed ID: 19815305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual porphyria in double heterozygotes with porphobilinogen deaminase and uroporphyrinogen decarboxylase deficiencies.
    Doss MO
    Clin Genet; 1989 Feb; 35(2):146-51. PubMed ID: 2721023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protoporphyrinaemia and decreased activities of 5-aminolevulinic acid dehydrase and uroporphyrinogen I synthetase in erythrocytes of a Vitamin B6-deficient epileptic boy given valproic acid and carbamazepine.
    Haust HL; Poon HC; Carson R; VanDeWetering C; Peter F
    Clin Biochem; 1989 Jun; 22(3):201-11. PubMed ID: 2500271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies in porphyria. VI. Biosynthesis of porphyrins in mammalian skin and in the skin of porphyric patients.
    Bickers DR; Keogh L; Rifkind AB; Harber LC; Kappas A
    J Invest Dermatol; 1977 Jan; 68(1):5-9. PubMed ID: 830770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant of acute intermittent porphyria with normal erythrocyte uroporphyrinogen-I-synthase activity.
    Mustajoki P; Tenhunen R
    Eur J Clin Invest; 1985 Oct; 15(5):281-4. PubMed ID: 3935460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.